After-Hours Movers 02/11: (RLGT) (CHGG) (VKTX) Higher; (VRNS) (LABL) (CMP) (more...)

February 11, 2019 5:27 PM

Today's After-Hours Movers

Varonis Systems (NASDAQ: VRNS) 19% LOWER; reported Q4 EPS of $0.54, $0.20 better than the analyst estimate of $0.34. Revenue for the quarter came in at $87.5 million versus the consensus estimate of $87.34 million. Varonis Systems sees Q1 2019 EPS of ($0.38)-($0.36), versus the consensus of ($0.23). Varonis Systems sees Q1 2019 revenue of $58.5-60 million, versus the consensus of $62.84 million. Varonis Systems sees FY2019 EPS of $0.04-$0.16, versus the consensus of $0.32. Varonis Systems sees FY2019 revenue of $297-305 million, versus the consensus of $318.47 million.

Multi-Color Corp. (NASDAQ: LABL) 17.1% LOWER; reported Q3 EPS of $0.50, $0.29 worse than the analyst estimate of $0.79. Revenue for the quarter came in at $397 million versus the consensus estimate of $412.24 million. Multi-Color Corp. sees FY2019 EPS of $3.50-$3.90, versus the consensus of $4.25. Today, the Company also announced that its Board of Directors is exploring strategic alternatives to enhance shareholder value, including, among other things, the potential sale of the Company.

Radiant Logistics (NYSE: RLGT) 12.6% HIGHER; reported Q2 EPS of $0.16, $0.05 better than the analyst estimate of $0.11. Revenue for the quarter came in at $260.9 million versus the consensus estimate of $230.01 million.

Chegg (NYSE: CHGG) 9.2% HIGHER; reported Q4 EPS of $0.25, $0.04 better than the analyst estimate of $0.21. Revenue for the quarter came in at $95.7 million versus the consensus estimate of $91.65 million. Chegg sees Q1 2019 revenue of $93.5-95.5 million, versus the consensus of $93.3 million. Chegg sees FY2019 revenue of $390-395 million, versus the consensus of $388.4 million.

Compass Minerals (NYSE: CMP) 8.8% LOWER; reported Q4 EPS of $1.41, $0.32 worse than the analyst estimate of $1.73. Revenue for the quarter came in at $486.5 million versus the consensus estimate of $503.87 million.

Viking Therapeutics (NASDAQ: VKTX) 8.5% HIGHER; Gains Post-Market Following Gilead's Study Failure

MoneyGram (NASDAQ: MGI) 7% LOWER; reported Q4 EPS of $0.01, $0.12 worse than the analyst estimate of $0.13. Revenue for the quarter came in at $345.8 million versus the consensus estimate of $359.1 million.

Pyxus International (NYSE: PYX) 6.6% HIGHER; reported Q3 EPS of ($0.56), versus $9.80 reported last year. Revenue for the quarter came in at $524.5 million, versus $477.78 million reported last year.

Mimecast Limited (NASDAQ: MIME) 6.3% HIGHER; reported Q3 EPS of $0.90, $0.84 better than the analyst estimate of $0.06. Revenue for the quarter came in at $87.6 million versus the consensus estimate of $84.78 million. Mimecast Limited sees Q4 2019 revenue of $90.6-91.5 million, versus the consensus of $87.8 million. Mimecast Limited sees FY2019 revenue of $338.7-339.7 million, versus the consensus of $333.2 million.

Amkor Technology (NASDAQ: AMKR) 6.3% LOWER; reported Q4 EPS of $0.12, $0.04 better than the analyst estimate of $0.08. Revenue for the quarter came in at $1.08 billion versus the consensus estimate of $1.06 billion. Amkor Technology sees Q1 2019 revenue of $840-920 million, versus the consensus of $1.01 billion.

AG Mortgage Investment Trust, Inc. (NYSE: MITT) 3.6% LOWER; announced today that it intends to offer 3,000,000 shares of its common stock in an underwritten public offering.

Gilead Sciences, Inc. (Nasdaq: GILD) 3.3% LOWER; announced that STELLAR-4, a Phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of selonsertib, an investigational, once-daily, oral inhibitor of apoptosis signal-regulating kinase 1 (ASK1), in patients with compensated cirrhosis (F4) due to nonalcoholic steatohepatitis (NASH), did not meet the pre-specified week 48 primary endpoint of a 1-stage histologic improvement in fibrosis without worsening of NASH.

Ringcentral, Inc. (NYSE: RNG) 3% HIGHER; reported Q4 EPS of $0.23, $0.05 better than the analyst estimate of $0.18. Revenue for the quarter came in at $189 million versus the consensus estimate of $181.05 million. Ringcentral, Inc. sees Q1 2019 EPS of $0.14-$0.16, versus the consensus of $0.15. Ringcentral, Inc. sees Q1 2019 revenue of $191.5-194.5 million, versus the consensus of $188.93 million. Ringcentral, Inc. sees FY2019 EPS of $0.69-$0.73, versus the consensus of $0.71. Ringcentral, Inc. sees FY2019 revenue of $847-859 million, versus the consensus of $823.04 million.

New Mountain Finance Corporation (NYSE: NMFC) 2.8% LOWER; announced today that it has commenced an underwritten offering of 3,750,000 shares of its common stock

Molina Healthcare (NYSE: MOH) 1.7% HIGHER; reported Q4 EPS of $3.07, $1.55 better than the analyst estimate of $1.52. Revenue for the quarter came in at $4.66 billion versus the consensus estimate of $4.55 billion. Molina Healthcare sees FY2019 EPS of $9.25-$9.75, versus the consensus of $9.29. Molina Healthcare sees FY2019 revenue of $16.3 billion, versus the consensus of $17.21 billion.

Categories

Special Reports

Next Articles